Dolutegravir Plus Lamivudine as First-Line Regimen in a Multicenter Cohort of HIV-1-Infected Patients: Preliminary Data from Clinical Practice

MeSH terms

• Adult
• Anti-HIV Agents / therapeutic use*
• CD4 Lymphocyte Count
• Cohort Studies
• Drug Therapy, Combination
• Female
• HIV Infections / drug therapy*
• HIV Infections / virology
• HIV-1 / drug effects
• Heterocyclic Compounds, 3-Ring / therapeutic use*
• Humans
• Lamivudine / therapeutic use*
• Male
• Middle Aged
• Mutation
• Oxazines / therapeutic use*
• Piperazines / therapeutic use*
• Practice Patterns, Physicians'
• Preliminary Data
• Pyridones / therapeutic use*
• RNA, Viral / blood
• Sustained Virologic Response